How a drug marketing ruling could limit future behavioral ad regulations
Does the First Amendment allow governments to regulate behavioral advertising? That question wasn’t the Supreme Court’s focus in the case of IMS v. Sorrell. But Thursday’s decision striking down a Vermont regulation of drug industry marketing practices could have implications for privacy law more generally. Ars talked to two legal experts about the merits of the decision and what it says about the future of privacy on the Internet.
This is your court on drugs
Drug companies market their wares by dispatching sales representatives, known as “detailers,” to meet individually with doctors. Detailers explain new products, answer questions about existing products, and provide information they hope will convince the doctors to prescribe their employers’ products more often.
Posted via email from I Have No Pants And I Must Scream | Comment »
← Previous Post Next Post →
